Search - tctmd.com

Displaying 1 - 20 of 1021

Sort: Relevancy | Date

News Conference News TCT 2016

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Michael O'Riordan

November 08, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Shelley Wood

November 07, 2016

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Conference News TCT 2016

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Michael O'Riordan

November 02, 2016

Presentation TCT 2016

Featured Lecture: Hemodynamic and Device-Directed Approaches to Patients With Shock and Heart Failure

Presenter: William T. Abraham, Srihari S. Naidu, Navin K. Kapur

November 02, 2016

Presentation TCT 2016

AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Presenter: Martin B. Leon, Louis A. Cannon, David Hildick-Smith

November 02, 2016

Presentation TCT 2016

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Presenter: Martin B. Leon, Louis A. Cannon, David R. Holmes Jr.

November 02, 2016

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

Presentation TCT 2016

Management of Residual Leaks After LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw

November 01, 2016

Presentation TCT 2016

Transfemoral Large Hole Closure Devices: Manta, Inseal, and Others

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Alexandre Abizaid

November 01, 2016

Presentation TCT 2016

Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw

November 01, 2016

Presentation TCT 2016

Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations

Presenter: Aaron V. Kaplan, Rachel Neubrander, Tamara Syrek Jensen

November 01, 2016

Presentation TCT 2016

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Cheng-Han Chen

November 01, 2016

Presentation TCT 2016

Follow-up Evaluation After LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw, Bushra S Rana

November 01, 2016

Presentation TCT 2016

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

Presenter: Aaron V. Kaplan, Rachel Neubrander, Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

New Valvuloplasty Devices II: InterValve V8 Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Wesley R. Pedersen

November 01, 2016

Presentation TCT 2016

Next Generation IVUS and OCT: HD-IVUS, Heartbeat-OCT, Micro-OCT, Combination Devices, and More

Presenter: Adrian P. Banning, Ryan D. Madder, Evelyn S. Regar

November 01, 2016

Presentation TCT 2016

New Valvuloplasty Devices I: Pi-cardia Leaflex Aortic Valve Remodeling Therapy

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Michael Jonas

November 01, 2016

Advertisement

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Featured Lecture: Hemodynamic and Device-Directed Approaches to Patients With Shock and Heart Failure

AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Management of Residual Leaks After LAA Closure

Transfemoral Large Hole Closure Devices: Manta, Inseal, and Others

Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure

Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Follow-up Evaluation After LAA Closure

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

New Valvuloplasty Devices II: InterValve V8 Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Next Generation IVUS and OCT: HD-IVUS, Heartbeat-OCT, Micro-OCT, Combination Devices, and More

New Valvuloplasty Devices I: Pi-cardia Leaflex Aortic Valve Remodeling Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content